Tag: Axel Merseburger

Do we need to continue androgen deprivation therapy?

Fortunately, a growing number of treatment options exist to treat metastatic castrate-resistant prostate cancer (mCRPC); however, with these newer options many questions about optimising treatment remain unanswered. There is an on-going discussion on the value and need of androgen...
A Challenger in Davos Series: Dr. Axel Merseburger

A Challenger in Davos Series: Dr. Axel Merseburger

The date for the 2014 European Urology Forum is coming closer. Between 1 and 4 February, professionals will gather in Davos, Switzerland, to challenge current urological methods and treatments and identify possible developments. One of the most awaited parts...
Guidelines Office at the EAU Annual Congress

Guidelines Office at the EAU Annual Congress

The session with Axel Merseburger drew great interest, and we think, very much endorsed the principle of assembling an ad hoc panel to look at an important topic from the unbiased and neutral position of assessing published evidence using...